#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Colorectal cancer metastatic Obesity Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Malignant fibrous histiocytoma Retinal dystrophy Thyroid cancer metastatic Adrenoleukodystrophy Squamous cell carcinoma of the oral cavity Insulinoma Uveal melanoma Pulmonary sarcoidosis Mantle cell lymphoma Ewing's sarcoma Liposarcoma recurrent Waldenstrom's macroglobulinaemia Biliary neoplasm Rhabdoid tumour Conjunctivitis allergic More trials…

    Learn about Rare Diseases

    Uterine leiomyosarcoma – Basic Information SAPHO syndrome – Treatment Bronchiolitis obliterans syndrome – Life with Disease Mantle cell lymphoma stage II – Trials in Disease Mucopolysaccharidosis I – Trials in Disease Ornithine transcarbamoylase deficiency – Trials in Disease CADASIL – Treatment Pituitary-dependent Cushing’s syndrome – Basic Information Haemophilia B without inhibitors – Diagnostics Marginal zone lymphoma refractory – Trials in Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    VELPATASVIR Calcium Pantothenate Bp Metoprolol At-1501 Midodrine Hydrochloride Sodium Sulfate Anhydrous Topiramate Rtp-026 Sodium Oxybuprocaine Sacubitril Valsartan Lanreotide Follitropin Alfa ICOTROKINRA Enlicitide Chloride 68Ganota-Anti-Her2 Vhh1 Mesna Iptacopan Hydrochloride Calcium Levofolinate DNL593 Lorlatinib More therapies…

    Learn about Your Condition

    Pneumonia chlamydial End stage renal disease Desmoplastic melanoma Spinal pain Adrenal insufficiency Anorexia nervosa Glanzmann's disease Anal cancer Metabolic syndrome Rheumatic disorder Ovarian cancer metastatic Chorioretinitis Drug dependence Testicular germ cell cancer Glaucoma More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Congenital, Hereditary, and Neonatal Diseases and Abnormalities

  • Study on the Effects of Exagamglogene Autotemcel for Patients with Transfusion-Dependent Beta-Thalassemia or Severe Sickle Cell Disease

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Sickle cell anaemia
    • Thalassaemia beta
    Investigated Drugs:
    • Exagamglogene Autotemcel
    • Plerixafor
    • Filgrastim
    Germany Italy

  • Study of Lu AG13909 in Adults with Cushing’s Disease to Evaluate Safety and Effectiveness

    Recruiting

    2 1 1
    Investigated Diseases:
    • Pituitary-dependent Cushing’s syndrome
    Investigated Drugs:
    • Ag13909
    France Hungary Italy Poland Romania Spain

  • Study on the Safety and Effects of NXT007 for Patients with Severe or Moderate Hemophilia A

    Recruiting

    1 1 1
    Investigated Diseases:
    • Factor VIII deficiency
    Investigated Drugs:
    • Ro7589655
    Italy Poland Spain

  • Study on the Effects of Sirolimus and Drug Combination for Children Under 4 Months with Tuberous Sclerosis Complex

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Tuberous sclerosis complex
    Investigated Drugs:
    • Carbamazepine
    • Oxcarbazepine
    • Phenobarbital
    Austria Germany

  • Study on the Safety and Effects of Cipaglucosidase Alfa and Miglustat for Children with Infantile-onset Pompe Disease

    Recruiting

    3 1 1
    Investigated Diseases:
    • Glycogen storage disease type II
    Investigated Drugs:
    • Cipaglucosidase Alfa
    • Miglustat
    Denmark France Germany Italy The Netherlands

  • Long-Term Safety Study of NTLA-2002 for Patients with Hereditary Angioedema, Using Messenger RNA Encoding Cas9 and HU-G012267

    Recruiting

    1 1 1
    Investigated Diseases:
    • Hereditary angioedema
    Investigated Drugs:
    • Lonvoguran
    • Ziclumeran
    France Germany The Netherlands
Previous Page
1 … 13 14 15 16 17 … 45
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!